International medical tourism of US cancer patients for alternative cancer treatments: Financial, demographic, and clinical profiles of online crowdfunding campaigns

Background Previous research has found that individuals may travel outside their home countries in pursuit of alternative cancer therapies (ACT). The goal of this study is to compare individuals in the United States who propose plans for travel abroad for ACT, compared with individuals who seek ACT...

Full description

Saved in:
Bibliographic Details
Published in:Cancer medicine (Malden, MA) Vol. 12; no. 7; pp. 8871 - 8879
Main Authors: Peterson, John, Wilson, Trevor F., Watt, Melissa H., Gruhl, Josh, Davis, Sydney, Olsen, Jaxon, Parsons, Matthew W., Kann, Benjamin H., Swire‐Thompson, Briony, Fagerlin, Angela, Warner, Echo L., King, Andy J., Chino, Fumiko, Johnson, Skyler B.
Format: Journal Article
Language:English
Published: United States John Wiley & Sons, Inc 01-04-2023
John Wiley and Sons Inc
Wiley
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Background Previous research has found that individuals may travel outside their home countries in pursuit of alternative cancer therapies (ACT). The goal of this study is to compare individuals in the United States who propose plans for travel abroad for ACT, compared with individuals who seek ACT domestically. Methods Clinical and treatment data were extracted from campaign descriptions of 615 GoFundMe® campaigns fundraising for individuals in the United States seeking ACT between 2011 and 2019. We examined treatment modalities, treatment location, fundraising metrics, and online engagement within campaign profiles. Clinical and demographic differences between those who proposed international travel and those who sought ACT domestically were examined using two‐sided Fisher's exact tests. Differences in financial and social engagement data were examined using two‐sided Mann–Whitney tests. Results Of the total 615 campaigns, 237 (38.5%) mentioned plans to travel internationally for ACT, with the majority (81.9%) pursuing travel to Mexico. Campaigns that proposed international treatment requested more money ($35,000 vs. $22,650, p < 0.001), raised more money ($7833 vs. $5035, p < 0.001), had more donors (57 vs. 45, p = 0.02), and were shared more times (377 vs. 290.5, p = 0.008) compared to campaigns that did not. The median financial shortfall was greater for campaigns pursuing treatments internationally (−$22,640 vs. ‐$13,436, p < 0.003). Conclusions Campaigns proposing international travel for ACT requested and received more money, were shared more online, and had more donors. However, there was significantly more unmet financial need among this group, highlighting potential financial toxicity on patients and families.
AbstractList BackgroundPrevious research has found that individuals may travel outside their home countries in pursuit of alternative cancer therapies (ACT). The goal of this study is to compare individuals in the United States who propose plans for travel abroad for ACT, compared with individuals who seek ACT domestically.MethodsClinical and treatment data were extracted from campaign descriptions of 615 GoFundMe® campaigns fundraising for individuals in the United States seeking ACT between 2011 and 2019. We examined treatment modalities, treatment location, fundraising metrics, and online engagement within campaign profiles. Clinical and demographic differences between those who proposed international travel and those who sought ACT domestically were examined using two-sided Fisher's exact tests. Differences in financial and social engagement data were examined using two-sided Mann–Whitney tests.ResultsOf the total 615 campaigns, 237 (38.5%) mentioned plans to travel internationally for ACT, with the majority (81.9%) pursuing travel to Mexico. Campaigns that proposed international treatment requested more money ($35,000 vs. $22,650, p < 0.001), raised more money ($7833 vs. $5035, p < 0.001), had more donors (57 vs. 45, p = 0.02), and were shared more times (377 vs. 290.5, p = 0.008) compared to campaigns that did not. The median financial shortfall was greater for campaigns pursuing treatments internationally (−$22,640 vs. -$13,436, p < 0.003).ConclusionsCampaigns proposing international travel for ACT requested and received more money, were shared more online, and had more donors. However, there was significantly more unmet financial need among this group, highlighting potential financial toxicity on patients and families.
Background Previous research has found that individuals may travel outside their home countries in pursuit of alternative cancer therapies (ACT). The goal of this study is to compare individuals in the United States who propose plans for travel abroad for ACT, compared with individuals who seek ACT domestically. Methods Clinical and treatment data were extracted from campaign descriptions of 615 GoFundMe® campaigns fundraising for individuals in the United States seeking ACT between 2011 and 2019. We examined treatment modalities, treatment location, fundraising metrics, and online engagement within campaign profiles. Clinical and demographic differences between those who proposed international travel and those who sought ACT domestically were examined using two‐sided Fisher's exact tests. Differences in financial and social engagement data were examined using two‐sided Mann–Whitney tests. Results Of the total 615 campaigns, 237 (38.5%) mentioned plans to travel internationally for ACT, with the majority (81.9%) pursuing travel to Mexico. Campaigns that proposed international treatment requested more money ($35,000 vs. $22,650, p < 0.001), raised more money ($7833 vs. $5035, p < 0.001), had more donors (57 vs. 45, p = 0.02), and were shared more times (377 vs. 290.5, p = 0.008) compared to campaigns that did not. The median financial shortfall was greater for campaigns pursuing treatments internationally (−$22,640 vs. ‐$13,436, p < 0.003). Conclusions Campaigns proposing international travel for ACT requested and received more money, were shared more online, and had more donors. However, there was significantly more unmet financial need among this group, highlighting potential financial toxicity on patients and families.
Abstract Background Previous research has found that individuals may travel outside their home countries in pursuit of alternative cancer therapies (ACT). The goal of this study is to compare individuals in the United States who propose plans for travel abroad for ACT, compared with individuals who seek ACT domestically. Methods Clinical and treatment data were extracted from campaign descriptions of 615 GoFundMe® campaigns fundraising for individuals in the United States seeking ACT between 2011 and 2019. We examined treatment modalities, treatment location, fundraising metrics, and online engagement within campaign profiles. Clinical and demographic differences between those who proposed international travel and those who sought ACT domestically were examined using two‐sided Fisher's exact tests. Differences in financial and social engagement data were examined using two‐sided Mann–Whitney tests. Results Of the total 615 campaigns, 237 (38.5%) mentioned plans to travel internationally for ACT, with the majority (81.9%) pursuing travel to Mexico. Campaigns that proposed international treatment requested more money ($35,000 vs. $22,650, p < 0 .001), raised more money ($7833 vs. $5035, p < 0 .001), had more donors (57 vs. 45, p = 0 .02), and were shared more times (377 vs. 290.5, p = 0 .008) compared to campaigns that did not. The median financial shortfall was greater for campaigns pursuing treatments internationally (−$22,640 vs. ‐$13,436, p < 0 .003). Conclusions Campaigns proposing international travel for ACT requested and received more money, were shared more online, and had more donors. However, there was significantly more unmet financial need among this group, highlighting potential financial toxicity on patients and families.
Previous research has found that individuals may travel outside their home countries in pursuit of alternative cancer therapies (ACT). The goal of this study is to compare individuals in the United States who propose plans for travel abroad for ACT, compared with individuals who seek ACT domestically. Clinical and treatment data were extracted from campaign descriptions of 615 GoFundMe® campaigns fundraising for individuals in the United States seeking ACT between 2011 and 2019. We examined treatment modalities, treatment location, fundraising metrics, and online engagement within campaign profiles. Clinical and demographic differences between those who proposed international travel and those who sought ACT domestically were examined using two-sided Fisher's exact tests. Differences in financial and social engagement data were examined using two-sided Mann-Whitney tests. Of the total 615 campaigns, 237 (38.5%) mentioned plans to travel internationally for ACT, with the majority (81.9%) pursuing travel to Mexico. Campaigns that proposed international treatment requested more money ($35,000 vs. $22,650, p < 0.001), raised more money ($7833 vs. $5035, p < 0.001), had more donors (57 vs. 45, p = 0.02), and were shared more times (377 vs. 290.5, p = 0.008) compared to campaigns that did not. The median financial shortfall was greater for campaigns pursuing treatments internationally (-$22,640 vs. -$13,436, p < 0.003). Campaigns proposing international travel for ACT requested and received more money, were shared more online, and had more donors. However, there was significantly more unmet financial need among this group, highlighting potential financial toxicity on patients and families.
Abstract Background Previous research has found that individuals may travel outside their home countries in pursuit of alternative cancer therapies (ACT). The goal of this study is to compare individuals in the United States who propose plans for travel abroad for ACT, compared with individuals who seek ACT domestically. Methods Clinical and treatment data were extracted from campaign descriptions of 615 GoFundMe® campaigns fundraising for individuals in the United States seeking ACT between 2011 and 2019. We examined treatment modalities, treatment location, fundraising metrics, and online engagement within campaign profiles. Clinical and demographic differences between those who proposed international travel and those who sought ACT domestically were examined using two‐sided Fisher's exact tests. Differences in financial and social engagement data were examined using two‐sided Mann–Whitney tests. Results Of the total 615 campaigns, 237 (38.5%) mentioned plans to travel internationally for ACT, with the majority (81.9%) pursuing travel to Mexico. Campaigns that proposed international treatment requested more money ($35,000 vs. $22,650, p < 0.001), raised more money ($7833 vs. $5035, p < 0.001), had more donors (57 vs. 45, p = 0.02), and were shared more times (377 vs. 290.5, p = 0.008) compared to campaigns that did not. The median financial shortfall was greater for campaigns pursuing treatments internationally (−$22,640 vs. ‐$13,436, p < 0.003). Conclusions Campaigns proposing international travel for ACT requested and received more money, were shared more online, and had more donors. However, there was significantly more unmet financial need among this group, highlighting potential financial toxicity on patients and families.
Author Davis, Sydney
Gruhl, Josh
King, Andy J.
Watt, Melissa H.
Kann, Benjamin H.
Peterson, John
Wilson, Trevor F.
Olsen, Jaxon
Johnson, Skyler B.
Chino, Fumiko
Fagerlin, Angela
Swire‐Thompson, Briony
Warner, Echo L.
Parsons, Matthew W.
AuthorAffiliation 5 Institute for Quantitative Social Science Harvard University Cambridge Massachusetts USA
10 Department of Radiation Oncology Memorial Sloan Kettering Cancer Center New York New York USA
4 Network Science Institute Northeastern University Boston Massachusetts USA
2 Department of Population Health Sciences University of Utah Salt Lake City Utah USA
6 Salt Lake City VA Informatics Decision‐Enhancement and Analytic Sciences (IDEAS) Center for Innovation Salt Lake City Utah USA
7 College of Nursing University of Utah Salt Lake City Utah USA
9 Department of Communication University of Utah Salt Lake City Utah USA
8 Cancer Control & Population Sciences Huntsman Cancer Institute Salt Lake City Utah USA
1 Department of Radiation Oncology University of Utah, Huntsman Cancer Institute Salt Lake City Utah USA
3 Department of Radiation Oncology, Dana‐Farber Cancer Institute/Brigham and Women's Hospital Harvard Medical School Boston Massachusetts USA
AuthorAffiliation_xml – name: 6 Salt Lake City VA Informatics Decision‐Enhancement and Analytic Sciences (IDEAS) Center for Innovation Salt Lake City Utah USA
– name: 4 Network Science Institute Northeastern University Boston Massachusetts USA
– name: 8 Cancer Control & Population Sciences Huntsman Cancer Institute Salt Lake City Utah USA
– name: 1 Department of Radiation Oncology University of Utah, Huntsman Cancer Institute Salt Lake City Utah USA
– name: 2 Department of Population Health Sciences University of Utah Salt Lake City Utah USA
– name: 3 Department of Radiation Oncology, Dana‐Farber Cancer Institute/Brigham and Women's Hospital Harvard Medical School Boston Massachusetts USA
– name: 5 Institute for Quantitative Social Science Harvard University Cambridge Massachusetts USA
– name: 7 College of Nursing University of Utah Salt Lake City Utah USA
– name: 10 Department of Radiation Oncology Memorial Sloan Kettering Cancer Center New York New York USA
– name: 9 Department of Communication University of Utah Salt Lake City Utah USA
Author_xml – sequence: 1
  givenname: John
  surname: Peterson
  fullname: Peterson, John
  organization: University of Utah, Huntsman Cancer Institute
– sequence: 2
  givenname: Trevor F.
  orcidid: 0000-0002-1311-2998
  surname: Wilson
  fullname: Wilson, Trevor F.
  organization: University of Utah, Huntsman Cancer Institute
– sequence: 3
  givenname: Melissa H.
  surname: Watt
  fullname: Watt, Melissa H.
  organization: University of Utah
– sequence: 4
  givenname: Josh
  orcidid: 0000-0003-3159-9936
  surname: Gruhl
  fullname: Gruhl, Josh
  organization: University of Utah, Huntsman Cancer Institute
– sequence: 5
  givenname: Sydney
  surname: Davis
  fullname: Davis, Sydney
  organization: University of Utah, Huntsman Cancer Institute
– sequence: 6
  givenname: Jaxon
  surname: Olsen
  fullname: Olsen, Jaxon
  organization: University of Utah, Huntsman Cancer Institute
– sequence: 7
  givenname: Matthew W.
  surname: Parsons
  fullname: Parsons, Matthew W.
  organization: University of Utah, Huntsman Cancer Institute
– sequence: 8
  givenname: Benjamin H.
  surname: Kann
  fullname: Kann, Benjamin H.
  organization: Harvard Medical School
– sequence: 9
  givenname: Briony
  surname: Swire‐Thompson
  fullname: Swire‐Thompson, Briony
  organization: Harvard University
– sequence: 10
  givenname: Angela
  surname: Fagerlin
  fullname: Fagerlin, Angela
  organization: Salt Lake City VA Informatics Decision‐Enhancement and Analytic Sciences (IDEAS) Center for Innovation
– sequence: 11
  givenname: Echo L.
  orcidid: 0000-0002-5998-9744
  surname: Warner
  fullname: Warner, Echo L.
  organization: Huntsman Cancer Institute
– sequence: 12
  givenname: Andy J.
  surname: King
  fullname: King, Andy J.
  organization: University of Utah
– sequence: 13
  givenname: Fumiko
  orcidid: 0000-0003-0498-488X
  surname: Chino
  fullname: Chino, Fumiko
  organization: Memorial Sloan Kettering Cancer Center
– sequence: 14
  givenname: Skyler B.
  orcidid: 0000-0002-8881-7706
  surname: Johnson
  fullname: Johnson, Skyler B.
  email: skyler.johnson@hci.utah.edu
  organization: Huntsman Cancer Institute
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36659856$$D View this record in MEDLINE/PubMed
BookMark eNp1ks9u3CAQxlGVqknTHPoCFVJPlbIJfwzYvVTRqklWStVDmzMCDA4rG1zwJsoD9T2LdzdRciiXQTMfv0Ez33twEGKwAHzE6AwjRM6NGqozxil_A44IqthCcFodvLgfgpOc16gcgQgX-B04pJyzpmb8CPxdhcmmoCYfg-rhYFtvSpziJvk8wOjg7S9oVDA2wbGobJgydDFB1e_f3dun-pSsmoZZ8RVe-lCSXvWnsLVD7JIa77w5hSq00PQ-bLuMKTrf2zy3iaFkCyrFh9ZtQutDV7jDqHwX8gfw1qk-25N9PAa3l99_L68XNz-vVsuLm4WpBOILKmqjiVNaCYK0QVwIK6xxxlrGhDaOt65GSCuKScNtg3FDa1HTlqPWCEvpMVjtuG1UazkmP6j0KKPycpuIqZMqTd70VjKGTEOpEQ1xleVcI0qxYkzTGuka68L6tmONG13GaspckupfQV9Xgr-TXbyXGGFaEY4L4fOekOKfjc2TXJe1lDVlSWrEK0QJYkX1Zacqo8s5WffcAiM5O0TODpGzQ4r208s_PSuf_FAE5zvBQ9nL4_9Jcnnxo9oi_wHWU8qr
Cites_doi 10.7202/1060911ar
10.1186/1472-6882-5-11
10.1001/jamaoncol.2017.2148
10.1093/jnci/djab141
10.1089/acm.2011.0022
10.1177/1534735419846986
10.1371/journal.pone.0229760
10.2196/34183
10.2105/AJPH.2020.305943
10.1016/j.socscimed.2021.114105
10.1001/jama.2018.16865
10.21873/anticanres.15168
10.2217/fon-2020-0440
10.1200/JCO.2006.09.6081
10.1371/journal.pone.0242048
10.1200/JCO.2004.08.182
10.1007/s00432-020-03191-0
10.1177/0047287520915278
10.1111/1467-9566.13568
10.1093/jnci/djx145
10.1007/s11606-010-1542-3
10.3322/caac.21443
10.1001/jamainternmed.2019.3330
ContentType Journal Article
Copyright 2023 The Authors. published by John Wiley & Sons Ltd.
2023 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2023 The Authors. published by John Wiley & Sons Ltd.
– notice: 2023 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
– notice: 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
WIN
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7X7
7XB
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
COVID
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M7P
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
5PM
DOA
DOI 10.1002/cam4.5636
DatabaseName Wiley Online Library
Wiley Free Archive
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
Coronavirus Research Database
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
Health & Medical Collection (Alumni Edition)
Biological Science Database
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Publicly Available Content Database
ProQuest Central Student
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Coronavirus Research Database
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest Central (Alumni)
DatabaseTitleList Publicly Available Content Database

CrossRef
MEDLINE

Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: http://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Peterson et al
EISSN 2045-7634
EndPage 8879
ExternalDocumentID oai_doaj_org_article_550c933c792f4e66b0331a55b380b81b
10_1002_cam4_5636
36659856
CAM45636
Genre researchArticle
Journal Article
Research Support, N.I.H., Extramural
GeographicLocations United States
United States--US
GeographicLocations_xml – name: United States
– name: United States--US
GrantInformation_xml – fundername: NIH/NCI
  funderid: P30 CA008748
– fundername: NCI NIH HHS
  grantid: P30 CA008748
– fundername: NIH/NCI
  grantid: P30 CA008748
GroupedDBID 0R~
1OC
24P
31~
53G
5VS
7X7
8-0
8-1
8FE
8FH
8FI
8FJ
AAHHS
AAZKR
ABDBF
ABUWG
ACCFJ
ACXQS
ADBBV
ADKYN
ADRAZ
ADZMN
ADZOD
AEEZP
AENEX
AEQDE
AFKRA
AIWBW
AJBDE
ALAGY
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AOIJS
AVUZU
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
CCPQU
D-8
D-9
DIK
EBS
EJD
FYUFA
GODZA
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
HYE
HZ~
IAO
IHR
KQ8
LK8
M48
M7P
M~E
O9-
OK1
OVD
PIMPY
PQQKQ
PROAC
RPM
TEORI
TUS
UKHRP
WIN
CGR
CUY
CVF
ECM
EIF
ITC
NPM
AAYXX
CITATION
3V.
7XB
8FK
AZQEC
COVID
DWQXO
GNUQQ
K9.
PQEST
PQUKI
PRINS
5PM
ID FETCH-LOGICAL-c4706-378cb2faba720bc0677e7ecfcee557bcf6df800ba31296e911938783d60dc7e33
IEDL.DBID RPM
ISSN 2045-7634
IngestDate Tue Oct 22 15:14:43 EDT 2024
Tue Sep 17 21:31:36 EDT 2024
Thu Oct 10 20:33:02 EDT 2024
Thu Sep 26 19:09:49 EDT 2024
Sat Sep 28 08:09:31 EDT 2024
Sat Aug 24 00:55:04 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords medical tourism
health misinformation
internet research
financial toxicity
alternative cancer therapy
Language English
License Attribution
2023 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4706-378cb2faba720bc0677e7ecfcee557bcf6df800ba31296e911938783d60dc7e33
ORCID 0000-0002-5998-9744
0000-0002-1311-2998
0000-0002-8881-7706
0000-0003-0498-488X
0000-0003-3159-9936
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134261/
PMID 36659856
PQID 2806403205
PQPubID 2032540
PageCount 9
ParticipantIDs doaj_primary_oai_doaj_org_article_550c933c792f4e66b0331a55b380b81b
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10134261
proquest_journals_2806403205
crossref_primary_10_1002_cam4_5636
pubmed_primary_36659856
wiley_primary_10_1002_cam4_5636_CAM45636
PublicationCentury 2000
PublicationDate April 2023
PublicationDateYYYYMMDD 2023-04-01
PublicationDate_xml – month: 04
  year: 2023
  text: April 2023
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Bognor Regis
– name: Hoboken
PublicationTitle Cancer medicine (Malden, MA)
PublicationTitleAlternate Cancer Med
PublicationYear 2023
Publisher John Wiley & Sons, Inc
John Wiley and Sons Inc
Wiley
Publisher_xml – name: John Wiley & Sons, Inc
– name: John Wiley and Sons Inc
– name: Wiley
References 2004; 22
2018; 320
2018; 110
2017; 3
2022
2019; 2
2020
2021; 114
2020; 110
2022; 8
2005; 5
2020; 16
2020; 15
2019; 179
2019; 18
2021; 282
2012; 18
2011; 26
2020; 146
2007; 87
2021; 60
2021; 41
2007; 25
2018; 68
e_1_2_12_4_1
e_1_2_12_3_1
e_1_2_12_6_1
e_1_2_12_5_1
e_1_2_12_19_1
e_1_2_12_18_1
e_1_2_12_2_1
e_1_2_12_17_1
e_1_2_12_16_1
Esmail N (e_1_2_12_11_1) 2007; 87
e_1_2_12_20_1
e_1_2_12_21_1
e_1_2_12_22_1
e_1_2_12_23_1
e_1_2_12_24_1
e_1_2_12_25_1
e_1_2_12_26_1
e_1_2_12_27_1
e_1_2_12_28_1
e_1_2_12_15_1
e_1_2_12_14_1
e_1_2_12_13_1
e_1_2_12_12_1
e_1_2_12_8_1
e_1_2_12_7_1
e_1_2_12_10_1
e_1_2_12_9_1
References_xml – volume: 5
  start-page: 11
  year: 2005
  article-title: Is complementary and alternative medicine (UNPROVEN CANCER TREATMENTS) cost‐effective? A systematic review
  publication-title: BMC Complement Altern Med
– volume: 282
  year: 2021
  article-title: Crowdfunding as a response to COVID‐19: increasing inequities at a time of crisis
  publication-title: Soc Sci Med
– volume: 18
  year: 2019
  article-title: Exploring the use of complementary and alternative medicine in cancer patients
  publication-title: Integr Cancer Ther
– volume: 18
  start-page: 235
  issue: 3
  year: 2012
  end-page: 241
  article-title: Use of complementary therapies for cancer symptom management: results of the 2007 National Health Interview Survey
  publication-title: J Altern Complement Med
– volume: 114
  start-page: djab141
  year: 2021
  end-page: djab1039
  article-title: Cancer misinformation and harmful information on Facebook and other social media: a brief report
  publication-title: J Natl Cancer Inst
– volume: 15
  issue: 3
  year: 2020
  article-title: A cross‐sectional study of social inequities in medical crowdfunding campaigns in the United States
  publication-title: PLoS One
– volume: 8
  issue: 2
  year: 2022
  article-title: Timing and motivations for alternative cancer therapy with insights from a crowdfunding platform: cross‐sectional mixed methods study
  publication-title: JMIR Cancer
– volume: 179
  start-page: 1717
  issue: 12
  year: 2019
  end-page: 1720
  article-title: Use of an online crowdfunding platform for unmet financial obligations in cancer care
  publication-title: JAMA Intern Med
– start-page: 1
  year: 2022
  end-page: 19
  article-title: Struggling, helping and adapting: crowdfunding motivations and outcomes during the early US COVID‐19 pandemic
  publication-title: Sociol Health Illn
– volume: 320
  start-page: 2417
  issue: 23
  year: 2018
  end-page: 2418
  article-title: Addressing health‐related misinformation on social media
  publication-title: Jama
– volume: 16
  start-page: 1883
  year: 2020
  end-page: 1888
  article-title: What is the alternative? Responding strategically to cancer misinformation
  publication-title: Future Oncol
– volume: 22
  start-page: 2489
  year: 2004
  end-page: 2503
  article-title: Herbal remedies in the United States: potential adverse interactions with anticancer agents
  publication-title: J Clin Oncol off J Am Soc Clin Oncol
– volume: 2
  start-page: 52
  issue: 2
  year: 2019
  end-page: 60
  article-title: Health misinformation and the power of narrative messaging in the public sphere
  publication-title: Can J BioethicsRevue Can Bioéthique
– volume: 25
  start-page: 180
  issue: 2
  year: 2007
  end-page: 186
  article-title: Cost of cancer care: issues and implications
  publication-title: J Clin Oncol
– volume: 60
  start-page: 779
  issue: 4
  year: 2021
  end-page: 798
  article-title: The medical tourism index and behavioral responses of medical travelers: a mixed‐method study
  publication-title: J Travel Res
– volume: 41
  start-page: 3759
  issue: 8
  year: 2021
  end-page: 3767
  article-title: The use of crowdfunding to support radiation therapy cancer treatments
  publication-title: Anticancer Res
– volume: 3
  start-page: 1582
  issue: 11
  year: 2017
  end-page: 1584
  article-title: Out‐of‐pocket costs, financial distress, and underinsurance in cancer care
  publication-title: JAMA Oncol
– volume: 87
  start-page: 1
  year: 2007
  end-page: 53
  article-title: Complementary and alternative medicine in Canada: trends in use and public attitudes, 1997‐2006
  publication-title: Public Policy Sources
– volume: 68
  start-page: 153
  issue: 2
  year: 2018
  end-page: 165
  article-title: The financial burden and distress of patients with cancer: understanding and stepping‐up action on the financial toxicity of cancer treatment
  publication-title: CA Cancer J Clin
– volume: 110
  start-page: 121
  issue: 1
  year: 2018
  end-page: 124
  article-title: Use of alternative medicine for cancer and its impact on survival
  publication-title: JNCI J Natl Cancer Inst
– volume: 146
  start-page: 1857
  issue: 7
  year: 2020
  end-page: 1865
  article-title: Use of GoFundMe® to crowdfund complementary and alternative medicine treatments for cancer
  publication-title: J Cancer Res Clin Oncol
– volume: 15
  issue: 11
  year: 2020
  article-title: Crowdfunding for complementary and alternative medicine: what are cancer patients seeking?
  publication-title: PLoS One
– volume: 26
  start-page: 399
  issue: 4
  year: 2011
  end-page: 404
  article-title: Use of complementary and alternative medicine and self‐rated health status: results from a National Survey
  publication-title: J Gen Intern Med
– volume: 110
  start-page: S270
  issue: Suppl 3
  year: 2020
  end-page: S272
  article-title: A prologue to the special issue: health misinformation on social media
  publication-title: Am J Public Health
– start-page: 61
  year: 2020
– ident: e_1_2_12_18_1
  doi: 10.7202/1060911ar
– ident: e_1_2_12_24_1
  doi: 10.1186/1472-6882-5-11
– ident: e_1_2_12_5_1
  doi: 10.1001/jamaoncol.2017.2148
– ident: e_1_2_12_19_1
  doi: 10.1093/jnci/djab141
– ident: e_1_2_12_2_1
– ident: e_1_2_12_9_1
  doi: 10.1089/acm.2011.0022
– ident: e_1_2_12_12_1
  doi: 10.1177/1534735419846986
– ident: e_1_2_12_23_1
  doi: 10.1371/journal.pone.0229760
– ident: e_1_2_12_7_1
  doi: 10.2196/34183
– ident: e_1_2_12_27_1
  doi: 10.2105/AJPH.2020.305943
– ident: e_1_2_12_22_1
  doi: 10.1016/j.socscimed.2021.114105
– ident: e_1_2_12_28_1
  doi: 10.1001/jama.2018.16865
– ident: e_1_2_12_21_1
  doi: 10.21873/anticanres.15168
– ident: e_1_2_12_17_1
  doi: 10.2217/fon-2020-0440
– ident: e_1_2_12_26_1
  doi: 10.1200/JCO.2006.09.6081
– ident: e_1_2_12_6_1
  doi: 10.1371/journal.pone.0242048
– ident: e_1_2_12_15_1
  doi: 10.1200/JCO.2004.08.182
– ident: e_1_2_12_16_1
  doi: 10.1007/s00432-020-03191-0
– ident: e_1_2_12_13_1
  doi: 10.1177/0047287520915278
– volume: 87
  start-page: 1
  year: 2007
  ident: e_1_2_12_11_1
  article-title: Complementary and alternative medicine in Canada: trends in use and public attitudes, 1997‐2006
  publication-title: Public Policy Sources
  contributor:
    fullname: Esmail N
– ident: e_1_2_12_20_1
  doi: 10.1111/1467-9566.13568
– ident: e_1_2_12_4_1
  doi: 10.1093/jnci/djx145
– ident: e_1_2_12_10_1
  doi: 10.1007/s11606-010-1542-3
– ident: e_1_2_12_14_1
– ident: e_1_2_12_25_1
  doi: 10.3322/caac.21443
– ident: e_1_2_12_3_1
– ident: e_1_2_12_8_1
  doi: 10.1001/jamainternmed.2019.3330
SSID ssj0000702671
Score 2.318418
Snippet Background Previous research has found that individuals may travel outside their home countries in pursuit of alternative cancer therapies (ACT). The goal of...
Previous research has found that individuals may travel outside their home countries in pursuit of alternative cancer therapies (ACT). The goal of this study...
Abstract Background Previous research has found that individuals may travel outside their home countries in pursuit of alternative cancer therapies (ACT). The...
BackgroundPrevious research has found that individuals may travel outside their home countries in pursuit of alternative cancer therapies (ACT). The goal of...
Abstract Background Previous research has found that individuals may travel outside their home countries in pursuit of alternative cancer therapies (ACT). The...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
wiley
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 8871
SubjectTerms Alliances
alternative cancer therapy
Alternative medicine
Beneficiaries
Cancer
Cancer therapies
Chemotherapy
Crowdfunding
Crowdsourcing
Demography
financial toxicity
Fund Raising
health misinformation
Humans
International travel
internet research
Medical Tourism
Neoplasms - epidemiology
Neoplasms - therapy
Patients
Radiation therapy
Social networks
Tourism
Toxicity
Travel
United States
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB5BD4gLgpZHoFRWxYFDQ107jrPcSumql3IplbhZfsIeNq2aVv1F_Z_M2MnSFSAu3KI4suPMeOabePwNwDuE3MHbqGqRZKwbbUNNvPt11I6j-0s85ENhJ2f6y7fu8zHR5KxKfVFOWKEHLh9uHxG0x6Db65lITWxb7EIeWKWc7LhDzJWtL-_uBVPZBmuqrHQwUQlxse_tsvmg2kzF_MsBZZ7-P4HL33Mk72PX7HzmT-HJiBrZYXnbZ_Ag9pvw6HTcF9-Cu7Ufe2xZdl_YdaEIZBeJnZ8xTwK-YiOT6sAQrrK8Wd5n8u-pfZV6Pnxk84mPY4-FuCzs1gu_x2wf2HSmko1lvwcaphBvMJz6bUCXSY4R-0WTs_jeD8_hfH789eikHgsw1L7RlBOnO-9Ess5qwZ0nsrmoo0_oWJXSzqc2JASczkpEDW1EuzmTne5kaHnwOkr5Ajb6iz6-AiY84hbPg4jcYsTjrBAOA1gVuE_YYCvYnaRiLgvPhimMysKQ6AyJroJPJK_VA0SNnW-gwphRYcy_FKaC7UnaZlyvg6H95YZqyasKXhbBr0aRbatmncLRuzWVWHuN9ZZ-8SMzdaO9kxSjVvA-a8_fp2aODk8bunj9P-b4Bh4LBGMlw2gbNq6vbuJbeDiEm528Tn4CfdgZ_Q
  priority: 102
  providerName: Directory of Open Access Journals
Title International medical tourism of US cancer patients for alternative cancer treatments: Financial, demographic, and clinical profiles of online crowdfunding campaigns
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fcam4.5636
https://www.ncbi.nlm.nih.gov/pubmed/36659856
https://www.proquest.com/docview/2806403205
https://pubmed.ncbi.nlm.nih.gov/PMC10134261
https://doaj.org/article/550c933c792f4e66b0331a55b380b81b
Volume 12
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6xPSAuiDehZWUhDhya3dSO7Sy3snRVhBYhlUrcIr9SViLZatOqv4j_ydiOV7sCLtyiOIptzdjzjWf8DcBbhNzWKMdz2jCXl1LZ3PPu507qAs1fU9hwKez8Qn75Xn088zQ5It2FCUn7Rq8m3c920q1-hNzK69ZMU57Y9OtyjmrEPPSfjmCE4HDHRw_7r_RVlU4SjVBBp0a15YQL5usVMSH4rPL1qnfsUKDr_xvG_DNVchfCBhu0eAQPB_BITuMgH8M91z2B-8shPP4Ufu2d75E2BmHITWQKJOuGXF4Q4-W8IQOhak8QtZIQM-8CB3hq32ag9-_JItFyHBPr2khyvTLHRHWWpKuVZKj-3ftuIv8GwanfWbSc3j7if3HnWV11_TO4XJx9m5_nQx2G3JTSp8bJymjaKK0kLbTxnHNOOtOgfeVcatMI2yDu1IoheBAOt88Zq2TFrCiskY6x53DQrTv3Egg1CF9MYakrFDo-WlGq0Y_ltjANNqgM3iSp1NeRbqOOxMq09lKsvRQz-ODltf3AM2SHF-vNVT3oSY2el5kxZuSMNqUTAlWPnSjONasKjVg9g6Mk7XpYtn3tw8ylLynPM3gRBb_tJSlOBtWeSuwNY78F9TcQdid9zeBd0J5_T62eny5L__Dq_3s5hAcUkVhMLzqCg5vNrXsNo97ejtFn-PR5HM4dxmHR_AYzzx3T
link.rule.ids 230,315,729,782,786,866,887,2108,27935,27936,53803,53805
linkProvider National Library of Medicine
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwEB3RIgEXyjeBAhbiwKHZTe04zvbWLl0tolshtZW4Wf5KWYlkq00rfhH_k7ETr3YFvfQWxVGcZJ49b-LxG4BPSLmtUY6ntGIuzYWyqdfdT53QGbq_KrNhU9j0TJz-KL8ce5mcIu6FCUn7Rs8Hza960Mx_htzKq9oMY57Y8PtsjDBinvoPt-A-DtiMrUXpYQYWvq7SfhQSyujQqDof8IL5ikWsKPio9BWr1zxREOz_H8v8N1lyncQGLzTZuevzP4HHPe8kh137U7jnmmfwYNavrD-HPxu_Bkndrd-Q605kkCwqcnFGjIfIkvRarC1BwkvCcnsT5MNj-yp5vT0gk6josUesqzt97LnZI6qxJO7KJH3h8NZ300l3EPxmvy06Xe9a8b44ac0vm_YFXEyOz8fTtC_hkJpc-Kw6URpNK6WVoJk2Xq7OCWcqdM2cC22qwlZIWbViyDsKhzPviJWiZLbIrBGOsZew3Swa9xoINch8TGapyxTGTFpRqjEE5jYzFTaoBD5Gc8qrTqlDdprMVHrzS2_-BI68oVcXeHHtcGKxvJS9iSQGbWbEmBEjWuWuKBC1bF9xrhFqGml-ArsRJrIf8a30K9S5r0bPE3jVIWbVS0RcAuUGljYeY7MFoRO0viNUEvgcYHf7q8nx4Sz3B2_u3ssHeDg9n53Ik6-n397CI4qErstS2oXt6-WNewdbrb15H0bbX_nVMZM
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Nb9QwEB3RIlVcKJ8lpYCFOHBoNqmdxNneyrarItiqUqnEzfJnWYnNrjat-EX8T8ZOvNoVcIFbFFtxHD973sTjNwDvkHIbLW2ZUsdsWnBpUq-7n1qucjR_LjfhUNj5Fb_4Wp-eeZmc43gWJgTtazUdNN9ng2b6LcRWLmY6i3Fi2eVkhDBinvpnC-OyLbiPkzYv1zz1sApzn1vpKIoJ5TTTclYMyor5rEWsqsph7bNWr1mjINr_J6b5e8DkOpENlmi8-z99eAQPe_5JTro6j-GebZ7AzqTfYX8KPzd-EZJZt49DbjuxQTJ35PqKaA-VJek1WVuCxJeEbfcmyIjH8lUQe3tMxlHZ45AYO-t0sqf6kMjGkHg6k_QJxFvfTCfhQfC7_TBofL2Jxefi4jW9adpncD0--zI6T_tUDqkuuI-u47VW1EklOc2V9rJ1llvt0ESXJVfaVcYhdVWSIf-oLK7AQ1bzmpkqN5pbxp7DdjNv7AsgVCMD0rmhNpfoOylJqUJXuDS5dlggE3gbh1QsOsUO0WkzU-EhIDwEEvjgB3tVwYtshxvz5Y3oh0mg86aHjGk-pK6wVYXoZUeyLBXCTSHdT-AgQkX0M78Vfqe68FnpywT2OtSsWomoS6DewNPGa2yWIHyC5neESwLvA_T-3jUxOpkU_mL_31t5AzuXp2Px-ePFp5fwgCKv64KVDmD7dnlnX8FWa-5ehwn3C3DkNBM
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=International+medical+tourism+of+US+cancer+patients+for+alternative+cancer+treatments%3A+Financial%2C+demographic%2C+and+clinical+profiles+of+online+crowdfunding+campaigns&rft.jtitle=Cancer+medicine+%28Malden%2C+MA%29&rft.au=Peterson%2C+John&rft.au=Wilson%2C+Trevor+F.&rft.au=Watt%2C+Melissa+H.&rft.au=Gruhl%2C+Josh&rft.date=2023-04-01&rft.issn=2045-7634&rft.eissn=2045-7634&rft.volume=12&rft.issue=7&rft.spage=8871&rft.epage=8879&rft_id=info:doi/10.1002%2Fcam4.5636&rft.externalDBID=10.1002%252Fcam4.5636&rft.externalDocID=CAM45636
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-7634&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-7634&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-7634&client=summon